David Ledbetter, Ph.D., FACMG

Executive Vice President & Chief Scientific Officer, Geisinger Health System

SFARI Investigator Website

David Ledbetter is a human geneticist with an American Board of Medical Genetics and Genomics certification in clinical cytogenetics. Ledbetter’s earlier work contributed to the discovery of the genetic causes of Prader-Willi and Miller-Dieker syndromes. Since then, his research has focused on developing and applying technologies to better understand neurodevelopmental conditions such as autism spectrum disorders. He has held leadership positions at the National Institutes of Health, the University of Chicago, Emory University, and is currently the Executive Vice President and Chief Scientific Officer of Geisinger Health System.

Read More

Funded Projects

SFARI Funded Publications

Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities. D'Angelo D., Lebon S., Chen Q., Martin-Brevet S., Snyder L.G., Hippolyte L., Hanson E., Maillard A.M., Faucett W.A., Macé A., Pain A., Bernier R., Chawner S.J., David A., Andrieux J., Aylward E., Baujat G., Caldeira I., Conus P., Ferrari C., Forzano F., Gérard M., Goin-Kochel R., Grant E., Hunter J., Isidor B., Jacquette A., Jonch A.E., Keren B., Lacombe D., Le Caignec C., Martin C.L., Männik K., Metspalu A., Mignot C., Mukherjee P., Owen M.J., Passeggeri M., Rooryck-Thambo C., Rosenfeld J.A., Spence S., Steinman K.J., Tjernagel J., Van Haelst M., Shen Y., Draganski B., Sherr E., Ledbetter D., van den Bree M.B., Beckmann J.S., Spiro J., Reymond A., Jacquemont S., Chung W., Cardiff University Experiences of Children With Copy Number Variants (ECHO) Study, the 16p11, 2 European Consortium, and the Simons Variation in Individuals Project (VIP) Consortium.
Subscribe to our newsletter and receive SFARI funding announcements and news